Employees Want Weight-Loss Drugs, but How Can Employers Afford the Costs?

Sponsored by
Demand for weight loss drugs keeps surging, but these medications come with a cost. Popular therapies such as GLP-1s can cost employers an estimated $1,000 per person per month, likely requiring long-term use. In 2024, organizations have already increased their health plan budgets by 5.2% as a result of GLP-1s. With 52% of professionals reporting a desire for weight-loss drug coverage, employers face a critical decision–how to provide access and improve overall health without breaking budgets. 

What you'll learn About demand trends for weight loss drugs and how to navigate employees' desire for coverage How Anti-obesity medications (AOMs) are shaping the future of weight management Strategies to provide cost-effective access to specialized obesity care How to maximize health outcomes for employees while driving a measurable ROI